Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Posts Tagged ‘NYSE:ABBV’
Billionaire Larry Robbins’ Big Q4 Moves in Humana Inc. (HUM), CIGNA Corporation (CI) and Others
Billionaire Larry Robbins, the founder of Glenview Capital Management, has been among the most scrutinized and closely-watched hedge fund managers in recent years due to his bullish...
Dividend Aristocrats Part 47: AbbVie Inc (ABBV)
When it comes to the hedge fund sentiment, AbbVie is a rather popular stocks among the funds tracked by Insider Monkey.
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Billionaire Glenn Russell Dubin’s 5 Best Stock Ideas for Q4
Highbridge Capital Management, led by Glenn Russell Dubin, recently filed its latest 13F with the U.S.
Billionaire Larry Robbins Has Mixed Sentiment On His Top Picks For Q4
Glenview Capital, led by Larry Robbins, recently submitted its 13F with the Securities and Exchange Commission, disclosing the long positions held in its portfolio at the end ...
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
The equity market returns were very disappointing in the third quarter, “thanks” to the slowdown of China’s economy and the weaker-than-expected U.S. economic data.
Billionaire Jim Simons’ Top High-Dividend Stock Picks
Most individual investors invest in dividend-paying stocks to benefit from the steady streams of dividend checks, but can also take advantage of stock price appreciation as...
Here Are This Elite Fund’s Top Stock Picks
Christopher C. Grisanti's Grisanti Brown & Partners is a successful hedge fund with a focus on consumer and healthcare stocks. Mr.
Are Beech Hill Advisors’ Top Biotech Stock Picks Poised For A Big Q4?
Beech Hill Advisors is a New York-based registered investment advisor founded by Paul Cantor and Joseph Weiss in 1987. Mr.
Woodford Investment Management Has A Lot Riding On These 5 Stocks
Woodford Investment Management recently filed its Form 13F with the U.S. Securities and Exchange Commission (SEC) for the reporting period of September 30.
A Look at Larry Robbins’ Take on the Pharma Industry and Four Picks He Is Bullish On
Larry Robbins of Glenview Capital is one of the most widely-watched investors on Wall Street.
Why Are These Four Stocks on the Move on Friday?
With the stock market ending the week on a positive note, boosted by strong earnings reported by tech giants, a number of stocks are trending amid large trading volume on the...
AbbVie, Biogen, Gilead: Smart Money Got Burned Betting on Biotech in Q3
When it rains, it pours, and for big pharma, it certainly poured in the third quarter.
These Stocks Were Upgraded This Morning And Hedge Funds Couldn’t Agree More
Analysts have been busy over the weekend, as a slew of stocks have received upgrades this morning, including one company which was on the receiving end of not one, but two such...
Here’s What Excited Hedge Funds Have To Say About AbbVie Inc (ABBV)
The $98.24 billion biopharmaceutical company AbbVie Inc (NYSE:ABBV) has sparked the attention of quite a few hedge funds according to the data we compiled from the last round ...
Billionaire Larry Robbins Has Healthy Stakes In Health Stocks
Glenview Capital, led by Larry Robbins, has recently published its 13F filing with the SEC, disclosing an equity portfolio worth $25.25 billion.
Hedge Funds Are Pouring Money Into These Stocks
With the data from the latest round of 13F filings now gathered and processed, we’ve identified five stocks that received a large influx of cash in the second quarter from the...
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.
Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)
Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E.
Deerfield Management’s Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)
James Flynn's Deerfield Management has filed its 13F with the SEC for the reporting period of March 31, with the investment manager disclosing a public equity portfolio valued...
AbbVie Is Buying Back $5 Billion in Stock. Hurray?
Who likes AbbVie (NYSE:ABBV) stock? AbbVie does! In fact, this pharmaceutical industry big-cap likes itself so much, it's planning to buy back $5 billion worth of its own stock...
AbbVie Inc (ABBV), Verizon Communications Inc. (VZ): Grisanti Brown & Partners’ Latest 13F Shows Focus on Consumer & Healthcare Stocks
Grisanti Brown & Partners is a multi-billion hedge fund, which focuses on Consumer and Healthcare stocks, managed by Christopher C. Grisanti.
Kris Jenner’s Rock Springs Capital Rides Healthcare Stocks to Big Q1 Gains
Rock Springs Capital Management, managed by Kris Jenner, Gordon Bussard, and Graham McPhail, a healthcare-focused fund based in Baltimore, Maryland rode its top biotech picks ...
John Paulson Big Bet On Whiting Petroleum Corp (WLL) Goes Sour With 64% Decline
Paulson & Co's John Paulson is one billionaire who would love to forget the past two years, which have turned out to be his worst as wrong energy stock bets turned out to be sour...
Express Scripts Holding Company (ESRX) Shuts Out Gilead Sciences Inc. (GILD) On A Cheaper Hepatitis C Treatment
Express Scripts Holding Company (NASDAQ:ESRX) desire to accord Hepatitis C patients with what it believes to be the best of care has seen it ink a discounted deal with AbbVie...
Hedge Fund News: John Paulson, Steven Cohen & Sandell Asset Management
John Paulson clearly did not see the collapse of pharmaceutical giant AbbVie Inc (NYSE:ABBV)’s deal with rival Shire coming.
Gilead Sciences Inc (GILD) And Merck & Co Inc (MRK) Fighting For 3 Billion-Per-Quarter Profits
Gilead Sciences, Inc. (NASDAQ:GILD), AbbVie Inc (NYSE:ABBV) and Merck & Co., Inc. (NYSE:MRK) have participated at the liver meeting in Boston, Massachusetts.
Hedge Fund News: Steven Cohen, Carl Icahn & Lansdowne Partners
The best thing federal prosecutors might have done for Steven A.
Hedge Fund News: Bruce Kovner, Seth Klarman & Brevan Howard
Caxton Associates LP, the hedge fund firm co-founded by billionaire Bruce Kovner, hired Philippe Fourcade, a former proprietary trader at BNP Paribas SA (EPA:BNP) Fourcade started...
Infinity Pharmaceuticals Inc. (INFI) and AbbVie Inc (ABBV) Stand Together Against Cancer
AbbVie Inc (NYSE:ABBV) will provide Infinity Pharmaceuticals Inc.
Shire PLC (ADR) (SHPG), Time Warner Cable (TWC): How John Paulson Got His Mojo Back
John Paulson’s funds posted strong returns in June, especially on the back of merger arbitrage plays, an activity in which Paulson has been involved for the last 20 years.
AbbVie Inc (ABBV) Seals Deal With Shire (SHPG), What Next?
AbbVie Inc (NYSE:ABBV) finally bought Dublin-based Shire PLC (ADR) (NASDAQ:SHPG) for 32 billion pounds or $54.7 billion after several unsuccessful bids.
AbbVie Inc. (ABBV) Closing on a $53 Billion Takeover of Shire PLC (ADR) (SHPG)
Questions are being asked as to whether Shire PLC (ADR) (NASDAQ:SHPG) shareholders will finally agree to the latest offer of £53.20 by AbbVie Inc.
Dividend Announcements Today: AbbVie, Cantel Medical and More
In a spate of dividend declarations today on June 19, 2014, AbbVie Inc. (NYSE:ABBV), IBERIABANK Corp (NASDAQ:IBKC), Cantel Medical Corp.
Highline Capital Management Bets on Healthcare, Basic Materials & Services Stocks
Highline Capital Management is a fund led by Jacob Doft.
Rock Springs Capital Management’s Top 5 Largest Stock Picks
Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent 14 years working at T.
Ken Fisher’s Stock Picks In The Dividend Space
Ken Fisher stocks: Ken Fisher’s stock purchases and his portfolio overview originally published at long-term-investments.blogspot.com.
AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): Does ChemoCentryx Inc (CCXI) Have a Platform Problem?
It hasn't been a fun month to be an investor in clinical-stage biotech ChemoCentryx Inc (NASDAQ:CCXI).
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?
The big biotech announced on Thursday that updated results from its phase 3 study of Pomalyst in treating relapsed or refractory multiple myeloma had been published online in ...
This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)
In the financial world, there are many methods market participants can use to track the equity markets.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Johnson & Johnson (JNJ), AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): The Impact of a Failed Crohn’s Disease Trial Study
A small section of the total Crohn's Disease) patient population is resistant to standard treatment options.
GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): ChemoCentryx Inc (CCXI) Collapses on Crohn’s Disease Results
Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat.
Hedge Funds Are Buying Bristol Myers Squibb Co. (BMY)
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): Profit From The Market’s Misunderstanding Of This Spinoff Company
When a company is spun off, there's a high level of forced selling.
Michael Kors Holdings Ltd (KORS), Phillips 66 (PSX), Kinder Morgan Inc (KMI): These IPO Stocks Have Been Winners
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
A Smart Eli Lilly & Co. (LLY) Investor Does What Now?
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
